Yang et al. reported that lipopolysaccharide (LPS) could promote PKM2 expression by activating the NF-κB signaling pathway in colorectal cancer and reverses TNF-α and IL-1β production and cell proliferation induced by LPS in colon cancer cells through knockout of PKM237. This evidence concerns the gene NFKB1 and colonic neoplasm.